Skip to content

Clinical study on the effect of shenfu on renal hemodynamics in septic patients with acute renal injury

Clinical study on the effect of shenfu on renal hemodynamics in septic patients with acute renal injury

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300067267
Enrollment
Unknown
Registered
2023-01-02
Start date
2023-01-02
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute kidney injury (AKI)

Interventions

experimental group:On the basis of standard treatment, add Shenfu injection 100ml+0.9% NS 250ml intravenous drip for 3 days
control group:On the basis of the standard treatment, 350ml of the same amount of normal saline was added for intravenous drip for 3 days

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of sepsis 3.0; 2. Aged >= 18 years; 3. Expected ICU stay >= 72 hours; 4. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with chronic renal insufficiency, anuria or oliguria requiring hemodialysis. 2. Patients who could not obtain basic renal function parameters. 3. Patients with a known history of allergy to sulfur hexafluoride or other components. 4. Patients with recent acute coronary syndrome or clinically unstable ischemic heart disease, including progressive or progressive myocardial infarction; Typical angina pectoris during the past 7 days of silence; Cardiac symptoms have worsened significantly in the past 7 days; Recent coronary interventional surgery or other factors suggestive of clinical instability (e.g. recent deterioration in ECG, laboratory or clinical findings); Acute heart failure, grade III/IV heart failure and severe arrhythmia. 5. Adult patients with respiratory distress syndrome with right-to-left shunt, severe pulmonary hypertension, uncontrolled hypertension, and no artificial airway.

Design outcomes

Primary

MeasureTime frame
creatinine;urea nitrogen;contrast-enhanced ultrasound measurement;urine output;

Countries

China

Contacts

Public ContactPu Hong

West China Hospital of Sichuan University

lc3428@126.com+86 138 8098 4773

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026